Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Titel:
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Auteur:
Habib, Ali A Zhao, Chongbo Aban, Inmaculada França Jr, Marcondes Cavalcante José, Jorge Gustavo zu Hörste, Gerd Meyer Klimiec-Moskal, Elżbieta Pulley, Michael T Tavolini, Darío Krumova, Petranka Lennon-Chrimes, Siân Smith, Jillian Thanei, Gian-Andrea Blondeau, Kathleen Vodopivec, Ivana Wolfe, Gil I Murai, Hiroyuki